XPAND GLOBAL // EXECUTIVE TOOL

Know the risk
before the launch.

Pressure-test key elements of your international direct selling model and identify where market-specific friction may require restructuring.

Regulatory Risk Diagnostic Country Market Intelligence Compensation Plan Evaluation Regulatory Watch Report
Executive Diagnostic Tool

Global Regulatory Exposure Diagnostic

Test your compensation targets and cross-border fulfillment against non-negotiable statutory caps before initiating foreign expansion.

48%
20% (Low) 35% (Korea Cap) 65% (High)

Binary, Unilevel, or Matrix plans paying bonuses across 2+ levels.

Fulfilling orders via courier/postal mail without local sanitary notifications.

Jurisdictional Basis: Screening references include South Korea's Act on Door-to-Door Sales Article 20, China's State Council Direct Selling Regulation (Order No. 443) and Regulation on Prohibition of Pyramid Selling (Order No. 444), plus market-specific import and consumer rules. Verify current law before acting.
89%

Critical regulatory vulnerability detected across target markets.

Unlock Your Exposure Scorecard

Enter your corporate details to view the calculated exposure tier and the statutory or operational issues triggered by your selections.

Executive screening only. Submission data may be processed by service providers used for automation and delivery. See the Privacy Policy.

Important: This diagnostic is an executive screening tool and is not legal advice. Statutes, enforcement practices, licensing requirements and product rules can change and should be confirmed with qualified local counsel before launch.